rs876659260
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PM4PP3PP5_Moderate
The NM_000546.6(TP53):c.716_736delACAGTTCCTGCATGGGCGGCA(p.Asn239_Gly245del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_000546.6 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.716_736del21 variant (also known as p.N239_G245del) is located in coding exon 6 of the TP53 gene. This variant results from an in-frame 21 nucleotide deletion between nucleotide positions 716 and 736 resulting in the deletion of codons 239 through 245 of the p53 protein. The seven nucleotides included in this deletion are involved in important aspects of p53 function and stability including DNA binding and zinc binding (Martin AC, Hum. Mutat. 2002 Feb; 19(2):149-64). Using a prediction software that analyzes the effect of small deletions, PROVEAN, this alteration was predicted to be highly deleterious (Choi Y, PLoS ONE 2012 ; 7(10):e46688). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at